ULBP2 and cancer: Recent comprehensive analyses of immune-related genes, using the Cancer Genome Atlas datasets and NanoString PanCancer Immune Profiling data, have identified ULBP2 as one of the top poor prognostic factors in both solid and hematopoietic malignancies [23,24,25,26,27,28,29,30,31].